Welcome to our dedicated page for TRANSCAT SEC filings (Ticker: TRNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TRANSCAT's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TRANSCAT's regulatory disclosures and financial reporting.
Transcat Inc Chief Human Resources Officer Theresa A. Conroy reported equity compensation activity rather than open-market trading. She received an award of 759 shares of common stock at $0.00 per share upon vesting of performance-based restricted stock units that were granted under the company’s 2021 Stock Incentive Plan and tied to adjusted EBITDA goals over a three-year period ending in fiscal 2026. To cover related taxes, 335 shares of common stock were withheld at $76.45 per share, a non-market disposition. Conroy also received a new grant of 1,382 restricted stock units that convert into common stock on a one-for-one basis and are scheduled to vest on March 31, 2029. After these transactions, she holds 2,361 shares of common stock directly and maintains multiple blocks of outstanding restricted stock units and a fully exercisable option for 2,000 shares at an exercise price of $63.17 per share expiring on May 25, 2027.
Transcat Inc Sr. VP Finance & CFO Thomas L. Barbato reported equity compensation activity involving performance-based restricted stock units and new awards. He received 1,719 shares of common stock upon vesting of performance-based RSUs granted under the 2021 Stock Incentive Plan, after the company met pre-determined adjusted EBITDA thresholds over a three-year period ending in fiscal 2026. To cover related tax obligations, 760 shares of common stock were withheld rather than sold on the open market. Barbato was also granted 3,925 new RSUs, which convert into common stock on a one-for-one basis and generally vest on March 31, 2029. Following these transactions, he directly holds 4,649 shares of common stock and continues to hold stock options and additional RSU awards with future vesting dates and option expirations in 2027 and 2028.
Transcat Inc. reported that President and CEO Jaime A. Irick received a grant of 15,043 restricted stock units (RSUs). These RSUs were awarded at no cash cost under the Transcat, Inc. 2021 Stock Incentive Plan and convert into common stock on a one-for-one basis.
According to the award terms, the RSUs generally vest on March 31, 2029, subject to the plan and award notice conditions. Following this grant, Irick holds 15,043 RSUs directly, reflecting a compensation-related equity award rather than an open-market share purchase or sale.
Transcat, Inc. files its annual report describing a calibration‑focused services and test equipment distribution business aimed at highly regulated industries such as life sciences, aerospace and energy. The company operates two segments, with Service positioned as the main long‑term growth driver.
Transcat runs 33 calibration service centers across North America and Ireland, added a Costa Rica lab in April 2026, and performs over 1.2 million calibrations annually for about 27,000 customers. Recent acquisitions include Essco in fiscal 2026, its largest deal, plus Martin and Becnel in fiscal 2025, all aimed at geographic expansion and capabilities.
The report highlights an Operational Excellence initiative, proprietary CalTrak® and C3® asset management platforms, and a strategy to cross‑sell between Service and Distribution. Key risks center on macroeconomic conditions, intense competition (including online and direct‑from‑vendor channels), acquisition integration, cybersecurity, supply chain disruptions and a $99.9 million debt balance under a $150 million credit facility.
Transcat, Inc. reported strong top-line growth but weaker earnings for its fiscal fourth quarter and full year ended March 28, 2026. Q4 revenue rose 15.8% to $89.3 million, led by 18.4% growth in service revenue to $61.6 million and 10.5% growth in distribution revenue to $27.8 million. Q4 gross margin improved to 34.1%, and Adjusted EBITDA* increased 16.0% to $14.8 million, but operating income fell 37.6% to $4.3 million and net income declined to $1.9 million, or $0.21 per diluted share.
For fiscal 2026, total revenue grew 19.2% to $331.9 million, with service revenue up 19.7% and distribution revenue up 18.2%. Full‑year gross margin expanded 50 basis points to 32.6% and Adjusted EBITDA* rose 22.7% to $48.7 million, while operating income decreased 25.8% to $13.3 million and net income dropped 63.0% to $5.4 million, or $0.57 per diluted share. Management attributes higher operating expenses to acquisitions, increased amortization, stock-based compensation, executive transition costs and incentives, and continues to guide to high single-digit service organic revenue growth for fiscal 2027.
Transcat, Inc. reported a change to executive compensation for its Chief Operating Officer, Michael W. West. Effective as of March 29, 2026, for the fiscal year ending March 27, 2027, Mr. West will receive a base salary of $425,000 per year, a target performance-based cash incentive equal to 40% of base salary, and a target long-term equity incentive equal to 65% of base salary. These elements together define his compensation opportunity for fiscal 2027.
Vanguard Capital Management reports beneficial ownership of 475,732 shares of Transcat Inc Common Stock, equal to 5.09% of the class as of 03/31/2026. The filing states Vanguard exercises sole dispositive power over 475,732 shares and sole voting power over 68,571 shares, and that these holdings include securities held for Vanguard funds and managed accounts.
Transcat, Inc. ownership filing: Royce & Associates reports beneficial ownership of 614,253 shares of Common Stock, representing 6.58% of the class as disclosed on 03/31/2026. The filing states Royce & Associates has sole voting and dispositive power over these shares and disclaims pecuniary interest.
Transcat Inc director and executive Jaime A. Irick has filed an initial insider ownership report. The Form 3 filing lists Irick as both a director and as President and CEO of Transcat Inc, with no insider transactions or derivative positions reported in this filing.
Transcat Inc. ownership filing: Ophir Asset Management Pty Ltd reports beneficial ownership of 482,038 shares of Transcat common stock, equal to 5.2% of the class. The filing breaks the position into two funds: 201,933 shares in Ophir Global Opportunities Fund and 280,105 shares in Ophir High Conviction Fund. The ownership percentage is calculated using 9,332,188 shares outstanding as reported on a Form 8-K filed February 3, 2026.